Evidence map›Paper›PMID 41753212›Full record

ArticleJournal of clinical medicine2026

Dupilumab-Related Hypereosinophilia in Patients Treated for Type 2 Diseases: Evidence from a 24-Month Prospective Real-Life Study.

Ilaria Mormile, Daniele La Prova, Paolo Pezzella, Giuliano Di Caprio, Amato de Paulis, Elena Cantone, Aikaterini Detoraki, Path2 Task-Force

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ilaria MormileDepartment of Translational Medical Sciences, Federico II University, 80131 Naples, Italy.ORCID 0000-0001-7599-5426
Daniele La ProvaPost-Graduate Program in Clinical Immunology and Allergy, University of Naples Federico II, 80131 Naples, Italy.ORCID 0009-0000-9308-2508
Paolo PezzellaDepartment of Neuroscience, Reproductive and Odontostomatological Sciences-ENT Section, University of Naples Federico II, 80131 Naples, Italy.ORCID 0009-0005-7237-2641
Giuliano Di CaprioPost-Graduate Program in Clinical Immunology and Allergy, University of Naples Federico II, 80131 Naples, Italy.
Amato de PaulisDepartment of Translational Medical Sciences, Federico II University, 80131 Naples, Italy.ORCID 0000-0003-0347-2540
Elena CantoneDepartment of Pharmacy and Health and Nutrition Sciences, University of Calabria, 87036 Rende, Italy.ORCID 0000-0002-7389-2033
Aikaterini DetorakiDivision of Internal Medicine and Clinical Immunology, Department of Internal Medicine and Clinical Complexity, University of Naples Federico II, 80131 Naples, Italy.ORCID 0000-0002-3692-1384
Path2 Task-Force

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

asthmachronic rhinosinusitis with nasal polypsdupilumabeosinophiliaeosinophilshypereosinophilia

Identifiers

PMID41753212
PMCPMC12942140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.